CN104940554A - Chinese herbal composition for treating heart diseases - Google Patents
Chinese herbal composition for treating heart diseases Download PDFInfo
- Publication number
- CN104940554A CN104940554A CN201510441994.5A CN201510441994A CN104940554A CN 104940554 A CN104940554 A CN 104940554A CN 201510441994 A CN201510441994 A CN 201510441994A CN 104940554 A CN104940554 A CN 104940554A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese herbal composition for treating heart diseases. The Chinese herbal composition is prepared from the following drug substances by weight: 20 to 30 parts of salvia miltiorrhiza, 20 to 30 parts of szechuan lovage rhizome, 15 to 25 parts of poria with hostwood, 15 to 25 parts of snakegourd peel, 15 to 25 parts of longstamen onion bulb, 20 to 30 parts of loranthus parasiticus, 10 to 15 parts of radix codonopsitis, 10 to 15 parts of calyx seu fructus physalis, 15 to 20 parts of paniculate swallowwort roots, 5 to 15 parts of coptis chinensis, 5 to 15 parts of alisma, 5 to 10 parts of fiveleaf akebia fruits, 5 to 10 parts of uncaria rhynchophylla, and 10 to 15 parts of rhodiola rosea. The Chinese herbal composition has the efficacies of tranquilizing mind by nourishing the heart, activating blood circulation to relieve pain, dispersing blood stasis to smooth veins, clearing away heart-fire for detoxification, nourishing blood and tonifying qi, is used for dialectical therapy of palpitation, shortness of breath, arhythmia, coronary heart disease, angina pectoris, myocardial infarction, heart failure, cardiopalmus and other heart diseases, and is fast in curative effect, low in cost, free of toxic and side effects, obvious in curative effect and capable of treating both symptoms and root causes.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, treat cardiopathic Chinese medicine composition in particular to one.
Background technology
Heart disease is the number one killer of human health, and the human mortality in the whole world 1/3 causes because of heart disease, and China, there is hundreds of thousands people to die from heart disease every year.After people enters old age, body yang-energy is more and more not enough, and is supplemented with drinking type, and wine has the instinct rising and float, and long-time liter is floated, and causes part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels yang-energy more not enough, causes kidney yang more empty.The appearance of in addition new life style, beverage as cold and cool in surfeit, cold food, cold and cool medicine all can damage human body; Under the infringement and induction of exopathogenic factor (typhoid fever), the moon is more contained, and sun more declines, so cause fire mutually more outer, go to heart, local heat energy increases, and occurs palpitating speed, and the heart is tired, nervous, vexed; Go to oral cavity then xerostomia, fire is outer mutually is more difficult to harness the river, then urine is many, and doctor trained in Western medicine inspection then can find that heart local changes.
Treat cardiopathic western drug variety in prior art more, from therapeutic effect, the Western medicine speed that takes effect is fast, give prominence to the remission curative effect of acute patient, but action time is short, side effect is larger, be difficult to effect a radical cure disease, easily recur, easily develop immunity to drugs and drug dependence, and it is expensive, common Western medicine such as: nitroglycerin is mainly used in preventing and treating angina pectoris, rapid-action, but narrow application range, effect is held time short, alleviates only and is difficult to effect a radical cure disease.Metoprolol is used for the treatment of hypertension, angina pectoris, myocardial infarction, hypertrophic cardiomyopathy, arrhythmia and heart neurosis etc., has certain curative effect, but larger to the unify side effect of digestive system of cardiovascular system, central nervous system.Nifedipine is used for the treatment of the diseases such as hypertension, angina pectoris, arrhythmia and hypertrophic neuropathy, rapid-action, can be used for first aid, but easily causes the side effect such as hypotension, headache, dizzy, weak, unusual type angina pectoris, periphery edema and shank tic.
Chinese medicine, by multipath, Mutiple Targets, the drug action of Integrate adjustment mechanisms play, has systemic feature, and Chinese patent medicine generally to have side effect little, the feature of taking convenience.At present, though there are some cardiopathic comprehensive improvement Chinese traditional patent formulations, dialectical mainly with QI and blood deficiency, heart arteries and veins stasis blocking, rich in nutrition opinion is controlled, and indication narrow scope, how imprecise curative effect is also.
Summary of the invention
The invention provides one and treat cardiopathic Chinese medicine composition, based on the dialectical prescription of tcm theory, there is effect of tranquilizing by nourishing the heart, promoting blood circulation and stopping pain, disperse blood stasis and dredge collateral, clearing away heart-fire detoxification, nourishing blood and invigorating qi, for to having palpitation, breathe hard, the various heart disease such as arrhythmia, coronary heart diseases and angina pectoris, myocardial infarction, heart failure, cardiopalmus carries out determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, curative effect is fast, and cost is low, has no side effect, therapeutic effect is remarkable, treating both the principal and secondary aspects of a disease.
Concrete, one aspect of the present invention provides one to treat cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part, Poria cum Radix Pini 15-25 part, Pericarpium Trichosanthis 15-25 part.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part, Poria cum Radix Pini 15-25 part, Pericarpium Trichosanthis 15-25 part, Bulbus Allii Macrostemonis 15-25 part, Herba Taxilli 20-30 part, Radix Codonopsis 10-15 part, Calyx Seu Fructus Physalis 10-15 part, Radix Cynanchi Paniculati 15-20 part, Rhizoma Coptidis 5-15 part, Rhizoma Alismatis 5-15 part, Fructus Akebiae 5-10 part, Ramulus Uncariae Cum Uncis 5-10 part, Radix Rhodiolae 10-15 part.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 20 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 15 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 20 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 10 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 5 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 5 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 10 parts.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 25 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 25 parts, Herba Taxilli 30 parts, Radix Codonopsis 15 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 20 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 15 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Rhodiolae 15 parts.
In the embodiment that the present invention one is concrete, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 30 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 15 parts.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 25 parts, Rhizoma Chuanxiong 25 parts, Poria cum Radix Pini 20 parts, Pericarpium Trichosanthis 20 parts, Bulbus Allii Macrostemonis 20 parts, Herba Taxilli 25 parts, Radix Codonopsis 13 parts, Calyx Seu Fructus Physalis 12 parts, Radix Cynanchi Paniculati 17 parts, Rhizoma Coptidis 10 parts, Rhizoma Alismatis 10 parts, Fructus Akebiae 7 parts, Ramulus Uncariae Cum Uncis 8 parts, Radix Rhodiolae 13 parts.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 23 parts, Poria cum Radix Pini 18 parts, Pericarpium Trichosanthis 21 parts, Bulbus Allii Macrostemonis 23 parts, Herba Taxilli 28 parts, Radix Codonopsis 14 parts, Calyx Seu Fructus Physalis 11 parts, Radix Cynanchi Paniculati 17 parts, Rhizoma Coptidis 8 parts, Rhizoma Alismatis 11 parts, Fructus Akebiae 8 parts, Ramulus Uncariae Cum Uncis 9 parts, Radix Rhodiolae 14 parts.
In the present invention's detailed description of the invention, described one treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 29 parts, Rhizoma Chuanxiong 22 parts, Poria cum Radix Pini 21 parts, Pericarpium Trichosanthis 16 parts, Bulbus Allii Macrostemonis 19 parts, Herba Taxilli 24 parts, Radix Codonopsis 13 parts, Calyx Seu Fructus Physalis 11 parts, Radix Cynanchi Paniculati 18 parts, Rhizoma Coptidis 7 parts, Rhizoma Alismatis 14 parts, Fructus Akebiae 6 parts, Ramulus Uncariae Cum Uncis 7 parts, Radix Rhodiolae 11 parts.
The cardiopathic Chinese medicine composition for the treatment of of the present invention can also be prepared according to the conventional method of the field of Chinese medicines, comprises soak by water etc.
Preferably, the preparation method of the cardiopathic Chinese medicine composition for the treatment of of the present invention, comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Poria cum Radix Pini, Pericarpium Trichosanthis, Radix Codonopsis, Calyx Seu Fructus Physalis, Rhizoma Alismatis, Ramulus Uncariae Cum Uncis are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C be 1.15-1.25 extractum (
);
(3) Radix Salviae Miltiorrhizae, Bulbus Allii Macrostemonis, Herba Taxilli, Radix Cynanchi Paniculati, Rhizoma Coptidis, Fructus Akebiae, Radix Rhodiolae are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C be 1.15-1.25 extractum (
);
(4) in step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, to obtain final product.
In a specific embodiment of the present invention, described preparation method, wherein adds the soak by water 3 times accounting for gross weight 10 times amount, each 1.5 hours in step (2); Account in step (3) in the alcoholic solution of 85% of gross weight 10 times amount and extract 2 times, each 3 hours.
The cardiopathic Chinese medicine composition for the treatment of of the present invention, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, granule.
Chinese medicine composition of the present invention, based on the dialectical prescription of tcm theory, there is effect of tranquilizing by nourishing the heart, promoting blood circulation and stopping pain, disperse blood stasis and dredge collateral, clearing away heart-fire detoxification, nourishing blood and invigorating qi, for to having palpitation, breathe hard, the various heart disease such as arrhythmia, coronary heart diseases and angina pectoris, myocardial infarction, heart failure, cardiopalmus carries out determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, curative effect is fast, and cost is low, has no side effect, therapeutic effect is remarkable, treating both the principal and secondary aspects of a disease.
Detailed description of the invention
Embodiment 1:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 20 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 15 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 20 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 10 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 5 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 5 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 10 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 2:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 20 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 15 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 20 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 10 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 5 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 5 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 10 parts;
Preparation method comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Poria cum Radix Pini, Pericarpium Trichosanthis, Radix Codonopsis, Calyx Seu Fructus Physalis, Rhizoma Alismatis, Ramulus Uncariae Cum Uncis are added the soak by water 3 times accounting for gross weight 8 times amount, each 2 hours, collecting decoction, then the aqueous solution adding that step (1) obtains, filter, relative density when filtrate is concentrated into 80 DEG C be 1.15-1.25 extractum (
);
(3) Radix Salviae Miltiorrhizae, Bulbus Allii Macrostemonis, Herba Taxilli, Radix Cynanchi Paniculati, Rhizoma Coptidis, Fructus Akebiae, Radix Rhodiolae are added account for gross weight 15 times amount 85% alcoholic solution in extract 2 times, each 2 hours, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C be 1.15-1.25 extractum (
);
(4) in step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, incapsulate and get final product.
Embodiment 3:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 25 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 25 parts, Herba Taxilli 30 parts, Radix Codonopsis 15 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 20 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 15 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Rhodiolae 15 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 4
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 30 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 15 parts;
Preparation method comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Poria cum Radix Pini, Pericarpium Trichosanthis, Radix Codonopsis, Calyx Seu Fructus Physalis, Rhizoma Alismatis, Ramulus Uncariae Cum Uncis are added the soak by water 3 times accounting for gross weight 8 times amount, each 2 hours, collecting decoction, then the aqueous solution adding that step (1) obtains, filter, relative density when filtrate is concentrated into 80 DEG C be 1.15-1.25 extractum (
);
(3) Radix Salviae Miltiorrhizae, Bulbus Allii Macrostemonis, Herba Taxilli, Radix Cynanchi Paniculati, Rhizoma Coptidis, Fructus Akebiae, Radix Rhodiolae are added account for gross weight 15 times amount 85% alcoholic solution in extract 2 times, each 2 hours, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C be 1.15-1.25 extractum (
);
(4) in step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, incapsulate and get final product.
Embodiment 5:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 25 parts, Rhizoma Chuanxiong 25 parts, Poria cum Radix Pini 20 parts, Pericarpium Trichosanthis 20 parts, Bulbus Allii Macrostemonis 20 parts, Herba Taxilli 25 parts, Radix Codonopsis 13 parts, Calyx Seu Fructus Physalis 12 parts, Radix Cynanchi Paniculati 17 parts, Rhizoma Coptidis 10 parts, Rhizoma Alismatis 10 parts, Fructus Akebiae 7 parts, Ramulus Uncariae Cum Uncis 8 parts, Radix Rhodiolae 13 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 6:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 23 parts, Poria cum Radix Pini 18 parts, Pericarpium Trichosanthis 21 parts, Bulbus Allii Macrostemonis 23 parts, Herba Taxilli 28 parts, Radix Codonopsis 14 parts, Calyx Seu Fructus Physalis 11 parts, Radix Cynanchi Paniculati 17 parts, Rhizoma Coptidis 8 parts, Rhizoma Alismatis 11 parts, Fructus Akebiae 8 parts, Ramulus Uncariae Cum Uncis 9 parts, Radix Rhodiolae 14 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 7:
One treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 29 parts, Rhizoma Chuanxiong 22 parts, Poria cum Radix Pini 21 parts, Pericarpium Trichosanthis 16 parts, Bulbus Allii Macrostemonis 19 parts, Herba Taxilli 24 parts, Radix Codonopsis 13 parts, Calyx Seu Fructus Physalis 11 parts, Radix Cynanchi Paniculati 18 parts, Rhizoma Coptidis 7 parts, Rhizoma Alismatis 14 parts, Fructus Akebiae 6 parts, Ramulus Uncariae Cum Uncis 7 parts, Radix Rhodiolae 11 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 8: Chinese medicine composition of the present invention is on the impact of Rat Experimental myocardial infarct size
Laboratory animal: Wistar rat, male, body weight 200 ~ 220g, is divided into 4 groups at random by 40, often organizes 10.
Rat Experimental myocardial infarction model: animal pentobarbital intraperitoneal injection of anesthesia (45mg/kg) is faced upward position and fixed.Tracheal intubation, makes the longitudinal incision of 2cm on the left of breastbone, and the 3rd, the 4th costicartilage is cut off in nearly breastbone side, after opening thoracic cavity, connects artificial respirator (ventilation 2ml/100g, 50 times/min).Cut off pericardium, expose heart, left anterior descending coronary artery root threading is in order to ligation, and record standard II lead electrocardiogram, stablizes 10 minutes, following coronary artery occlusion left anterior descending branch, closes thoracic cavity.By syringe sucking-off animal throat portion secretion, animal is made to recover autonomous respiration.After following coronary artery occlusion 15min, intravenously administrable.Following coronary artery occlusion is after 4 hours, win heart, crosscut 5 below ligature, carry out NBT (N-BT) dyeing, calculating myocardium infarct area accounts for the percentage ratio of ventricle and heart area, and carries out statistical procedures (t inspection).
Medication: rat is divided into 4 groups at random: model group (giving normal saline), the basic, normal, high dosage group of the present invention.Each medicine group gastric infusion, successive administration 7 days, every day 1 time, modeling as stated above after last administration 1h.The results are shown in Table 1.
| Group | Dosage (g/kg) | Infarcted region/ventricle (%) | Infarcted region/heart (%) |
| Model group | 7 | 38.58±6.18 | 29.72±5.12 |
| Low dose group of the present invention | 3 (being equivalent to the amount of medical material) | 18.26±5.48 ** | 13.87±5.28 ** |
| Dosage group in the present invention | 5(is equivalent to the amount of medical material) | 15.29±4.71 ** | 11.35±5.38 ** |
| High dose group of the present invention | 7(is equivalent to the amount of medical material) | 12.34±4.28 ** | 9.35±5.13 ** |
Note:
*p ﹤ 0.01, compared with model group.
From table 1 result, compared with model group, the present invention's each dosage group myocardial infarction area significantly reduces (P ﹤ 0.01), shows that Chinese medicine composition of the present invention can reduce the incidence rate of the cardiovascular disease such as coronary heart disease.
Embodiment 9 clinical data
1, physical data
Choose 100 routine patients with arrhythmia, man 50 example, female 50 example; The oldest 80 years old, minimum 30 years old, institute
Patient is had all to make a definite diagnosis through Electrocardioscopy.
2, Therapeutic Method
Use capsule obtained in embodiment 2 to treat, every day twice, each 2, treating 2 weeks is a course for the treatment of.Over the course for the treatment of, carry out cardiac auscultation, electrocardiographic oscillogram trace electrocardiogram, record arrhythmia conditions, and do 24 hr Ambulatory EKG Monitoring monitorings and blood, urine, stool routine, hepatic and renal function inspection.
3, criterion of therapeutical effect
Effective: cardiopalmus, tachypnea, uncomfortable in chest, chest pain disappearance, edema, two lung moist rales disappear, without premature beat, and normal ECG;
Effective: cardiopalmus, tachypnea, uncomfortable in chest, chest pain alleviate, two lung moist rales reduce, and premature beat reduces 50%, and ECG ST section recovers >=0.05 mV, T ripple and shoals and reach 50% before being comparatively admitted to hospital;
Invalid: clinical symptoms, sign and electrocardiogram are without obvious change.
4, therapeutic outcome
After 3 courses for the treatment of, effective 61 examples, effective 35 examples, invalid 4 examples, the present invention treats ARR total effective rate and reaches 96%.
Claims (8)
1. treat a cardiopathic Chinese medicine composition, be made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part.
2. one according to claim 1 treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part, Poria cum Radix Pini 15-25 part, Pericarpium Trichosanthis 15-25 part.
3. one according to claim 1 treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20-30 part, Rhizoma Chuanxiong 20-30 part, Poria cum Radix Pini 15-25 part, Pericarpium Trichosanthis 15-25 part, Bulbus Allii Macrostemonis 15-25 part, Herba Taxilli 20-30 part, Radix Codonopsis 10-15 part, Calyx Seu Fructus Physalis 10-15 part, Radix Cynanchi Paniculati 15-20 part, Rhizoma Coptidis 5-15 part, Rhizoma Alismatis 5-15 part, Fructus Akebiae 5-10 part, Ramulus Uncariae Cum Uncis 5-10 part, Radix Rhodiolae 10-15 part.
4. one according to claim 3 treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 20 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 15 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 20 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 10 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 5 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 5 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 10 parts.
5. one according to claim 3 treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 25 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 25 parts, Herba Taxilli 30 parts, Radix Codonopsis 15 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 20 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 15 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Rhodiolae 15 parts.
6. one according to claim 3 treats cardiopathic Chinese medicine composition, is made up of the crude drug of following weight portion: Radix Salviae Miltiorrhizae 20 parts, Rhizoma Chuanxiong 30 parts, Poria cum Radix Pini 15 parts, Pericarpium Trichosanthis 25 parts, Bulbus Allii Macrostemonis 15 parts, Herba Taxilli 30 parts, Radix Codonopsis 10 parts, Calyx Seu Fructus Physalis 15 parts, Radix Cynanchi Paniculati 15 parts, Rhizoma Coptidis 15 parts, Rhizoma Alismatis 5 parts, Fructus Akebiae 10 parts, Ramulus Uncariae Cum Uncis 5 parts, Radix Rhodiolae 15 parts.
7. the one described in claim 1-6 treats cardiopathic Chinese medicine composition, it is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
8. one according to claim 7 treats cardiopathic Chinese medicine composition, it is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510441994.5A CN104940554A (en) | 2015-07-27 | 2015-07-27 | Chinese herbal composition for treating heart diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510441994.5A CN104940554A (en) | 2015-07-27 | 2015-07-27 | Chinese herbal composition for treating heart diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104940554A true CN104940554A (en) | 2015-09-30 |
Family
ID=54155978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510441994.5A Pending CN104940554A (en) | 2015-07-27 | 2015-07-27 | Chinese herbal composition for treating heart diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104940554A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110183505A (en) * | 2019-04-19 | 2019-08-30 | 牡丹江医学院 | For improving the drug of the variation of ECG ST segment caused by myocardial infarction |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1200278A (en) * | 1997-05-26 | 1998-12-02 | 万福源 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
| CN1883553A (en) * | 2006-06-01 | 2006-12-27 | 河南辅仁药业集团有限公司 | A pharmaceutical composition for preventing and treating coronary heart disease and angina pectoris and method for preparing same |
| CN101104048A (en) * | 2006-07-14 | 2008-01-16 | 黄振华 | Compound medicine for pulse generating and treating coronary heart disease |
| CN102908583A (en) * | 2012-10-19 | 2013-02-06 | 吉林康乃尔药业有限公司 | Traditional Chinese medicine composition for treating chest stuffiness and pains as well as preparation method, quality detection method and application of composition |
-
2015
- 2015-07-27 CN CN201510441994.5A patent/CN104940554A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1200278A (en) * | 1997-05-26 | 1998-12-02 | 万福源 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
| CN1883553A (en) * | 2006-06-01 | 2006-12-27 | 河南辅仁药业集团有限公司 | A pharmaceutical composition for preventing and treating coronary heart disease and angina pectoris and method for preparing same |
| CN101104048A (en) * | 2006-07-14 | 2008-01-16 | 黄振华 | Compound medicine for pulse generating and treating coronary heart disease |
| CN102908583A (en) * | 2012-10-19 | 2013-02-06 | 吉林康乃尔药业有限公司 | Traditional Chinese medicine composition for treating chest stuffiness and pains as well as preparation method, quality detection method and application of composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110183505A (en) * | 2019-04-19 | 2019-08-30 | 牡丹江医学院 | For improving the drug of the variation of ECG ST segment caused by myocardial infarction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101011522B (en) | Chinese traditional medicine for treating cardiopathy | |
| CN101433689A (en) | Kudzu root and longstamen onion bulb oral liquid and preparation method | |
| CN101306138B (en) | Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method | |
| CN105287812A (en) | Medicine composition for treating irritable bowel syndromes and application of medicine composition | |
| CN101254266B (en) | Cardiac and cerebral vascular disease treating medicine | |
| CN1970050B (en) | Pharmaceutical composition for treating arrhythmia and preparation process thereof | |
| CN104940554A (en) | Chinese herbal composition for treating heart diseases | |
| CN103520684B (en) | Traditional Chinese medicine compound for reducing blood sugar | |
| CN102204956B (en) | Chinese medicinal composition used at stroke recovery period and preparation method thereof | |
| CN101773545B (en) | Leucocyte increasing medicament containing batyl alcohol | |
| CN101947299B (en) | Medicinal composition for treating coronary heart disease | |
| CN101632783B (en) | Application of Chinese medicinal composition in preparing medicament for treating cor pulmonale | |
| CN101417075B (en) | Traditional Chinese medicine for treating respiratory system disease | |
| CN103599485B (en) | A kind of Chinese medicine composition being used for the treatment of premature beat | |
| CN104524359B (en) | A kind of Chinese medicine composition, its preparation method and application | |
| CN103212041A (en) | Chinese medicinal composition treating coronary heart disease | |
| CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
| CN100441205C (en) | Medicine for treating blood system disease | |
| CN104208570A (en) | Traditional Chinese medicinal composition for treating heart failure, and preparation method thereof | |
| CN104189424A (en) | Traditional Chinese medicine composition for treating heart failure | |
| CN104857459A (en) | Heart failure treating traditional Chinese medicine composition and preparation method thereof | |
| CN101780142B (en) | Leukogenic medicament containing lithium carbonate | |
| CN104189288A (en) | Traditional Chinese medicine composition for treating myocardial infarction and application of traditional Chinese medicine composition | |
| CN116549520A (en) | Qi-blood tonifying, lung heat clearing and cough relieving traditional Chinese medicine formula, traditional Chinese medicine liquid and traditional Chinese medicine preparation | |
| CN101084997B (en) | Traditional Chinese medicine freezing-dried powder injection for treating cardiovascular and cerebrovascular diseases and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150930 |
|
| WD01 | Invention patent application deemed withdrawn after publication |